The global Gel Card Tests market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.

A gel card test, also known as a gel agglutination test, is a type of diagnostic test used in immunohematology to determine blood compatibility, blood group typing, and the presence of specific antibodies in blood samples. Gel card tests utilize gel matrix technology to simplify and expedite the process of performing multiple blood tests simultaneously in a single platform.

The Gel Card Method is based on the principles of agglutination and hemagglutination. Agglutination is the clumping together of particles – in this case, red blood cells (RBCs). The RBCs will agglutinate when mixed with sera containing the corresponding antibodies. The degree of agglutination in the microtubes within the gel card is then used to determine the blood group.

ReportPrime, Inc. (LPI) ' newest research report, the “Gel Card Tests Industry Forecast” looks at past sales and reviews total world Gel Card Tests sales in 2024, providing a comprehensive analysis by region and market sector of projected Gel Card Tests sales for 2025 through 2031. With Gel Card Tests sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gel Card Tests industry.

This Insight Report provides a comprehensive analysis of the global Gel Card Tests landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gel Card Tests portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gel Card Tests market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gel Card Tests and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gel Card Tests.

This report presents a comprehensive overview, market shares, and growth opportunities of Gel Card Tests market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Blood Grouping Forward and Reverse Test
• Cross Match Test
• Other

Segmentation by Application:

• Hospitals
• Research Centers
• Laboratory
• Others

This report also splits the market by region:

• Americas
• APAC
• Europe
• Middle East & Africa

Key Companies:

• Grifols
• Bio-Rad
• Ortho Clinical Diagnostics (QuidelOrtho)
• Turklab
• Tulip Diagnostics (PerkinElmer)
• Redcell Biotechnology
• Dia Pro Tıbbi Ürünler
• Aikang MedTech
• Tianjin Dexiang Biotech
• POLYRICHE BIOTECH
• Hubei Longtime Biological
• Singapore BioSciences

Key Questions Addressed in this Report:

1. What is the 10-year outlook for the global Gel Card Tests market?
2. What factors are driving Gel Card Tests market growth, globally and by region?
3. Which technologies are poised for the fastest growth by market and region?
4. How do Gel Card Tests market opportunities vary by end market size?
5. How does Gel Card Tests break out by Type, by Application?